vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and LIVEPERSON INC (LPSN). Click either name above to swap in a different company.

LIVEPERSON INC is the larger business by last-quarter revenue ($59.3M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -77.8%, a 73.0% gap on every dollar of revenue. On growth, LIVEPERSON INC posted the faster year-over-year revenue change (-19.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-12.0M). Over the past eight quarters, LIVEPERSON INC's revenue compounded faster (-16.6% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

LivePerson is a global technology company that develops conversational commerce and AI software.

IRWD vs LPSN — Head-to-Head

Bigger by revenue
LPSN
LPSN
1.2× larger
LPSN
$59.3M
$47.7M
IRWD
Growing faster (revenue YoY)
LPSN
LPSN
+28.3% gap
LPSN
-19.0%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
73.0% more per $
IRWD
-4.8%
-77.8%
LPSN
More free cash flow
IRWD
IRWD
$86.5M more FCF
IRWD
$74.6M
$-12.0M
LPSN
Faster 2-yr revenue CAGR
LPSN
LPSN
Annualised
LPSN
-16.6%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
LPSN
LPSN
Revenue
$47.7M
$59.3M
Net Profit
$-2.3M
$-46.1M
Gross Margin
73.2%
Operating Margin
14.3%
-68.7%
Net Margin
-4.8%
-77.8%
Revenue YoY
-47.3%
-19.0%
Net Profit YoY
-200.9%
58.9%
EPS (diluted)
$0.01
$-9.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
LPSN
LPSN
Q4 25
$47.7M
$59.3M
Q3 25
$122.1M
$60.2M
Q2 25
$85.2M
$59.6M
Q1 25
$41.1M
$64.7M
Q4 24
$90.5M
$73.2M
Q3 24
$91.6M
$74.2M
Q2 24
$94.4M
$79.9M
Q1 24
$74.9M
$85.1M
Net Profit
IRWD
IRWD
LPSN
LPSN
Q4 25
$-2.3M
$-46.1M
Q3 25
$40.1M
$8.7M
Q2 25
$23.6M
$-15.7M
Q1 25
$-37.4M
$-14.1M
Q4 24
$2.3M
$-112.1M
Q3 24
$3.6M
$-28.3M
Q2 24
$-860.0K
$41.8M
Q1 24
$-4.2M
$-35.6M
Gross Margin
IRWD
IRWD
LPSN
LPSN
Q4 25
73.2%
Q3 25
71.4%
Q2 25
69.7%
Q1 25
71.8%
Q4 24
77.4%
Q3 24
73.1%
Q2 24
79.4%
Q1 24
71.3%
Operating Margin
IRWD
IRWD
LPSN
LPSN
Q4 25
14.3%
-68.7%
Q3 25
61.8%
-24.2%
Q2 25
53.2%
-10.8%
Q1 25
-70.7%
-26.2%
Q4 24
34.8%
-138.0%
Q3 24
28.0%
-21.6%
Q2 24
26.5%
-37.3%
Q1 24
14.7%
-42.7%
Net Margin
IRWD
IRWD
LPSN
LPSN
Q4 25
-4.8%
-77.8%
Q3 25
32.8%
14.5%
Q2 25
27.7%
-26.4%
Q1 25
-90.9%
-21.8%
Q4 24
2.5%
-153.2%
Q3 24
4.0%
-38.1%
Q2 24
-0.9%
52.3%
Q1 24
-5.6%
-41.8%
EPS (diluted)
IRWD
IRWD
LPSN
LPSN
Q4 25
$0.01
$-9.22
Q3 25
$0.23
$-2.76
Q2 25
$0.14
$-0.17
Q1 25
$-0.23
$-0.24
Q4 24
$0.03
$-17.23
Q3 24
$0.02
$-4.74
Q2 24
$-0.01
$-0.33
Q1 24
$-0.03
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
LPSN
LPSN
Cash + ST InvestmentsLiquidity on hand
$215.5M
$95.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$-261.8M
$-44.5M
Total Assets
$396.9M
$454.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
LPSN
LPSN
Q4 25
$215.5M
$95.0M
Q3 25
$140.4M
$106.7M
Q2 25
$92.9M
$162.0M
Q1 25
$108.5M
$176.3M
Q4 24
$88.6M
$183.2M
Q3 24
$88.2M
$142.1M
Q2 24
$105.5M
$146.0M
Q1 24
$121.5M
$127.1M
Total Debt
IRWD
IRWD
LPSN
LPSN
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
$512.1M
Stockholders' Equity
IRWD
IRWD
LPSN
LPSN
Q4 25
$-261.8M
$-44.5M
Q3 25
$-264.2M
$-22.1M
Q2 25
$-308.2M
$-82.4M
Q1 25
$-334.1M
$-74.9M
Q4 24
$-301.3M
$-67.3M
Q3 24
$-311.3M
$45.9M
Q2 24
$-321.7M
$66.6M
Q1 24
$-330.5M
$19.2M
Total Assets
IRWD
IRWD
LPSN
LPSN
Q4 25
$396.9M
$454.7M
Q3 25
$396.1M
$511.4M
Q2 25
$342.9M
$604.2M
Q1 25
$327.2M
$596.2M
Q4 24
$350.9M
$607.8M
Q3 24
$389.5M
$692.0M
Q2 24
$395.6M
$703.8M
Q1 24
$438.8M
$724.7M
Debt / Equity
IRWD
IRWD
LPSN
LPSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
26.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
LPSN
LPSN
Operating Cash FlowLast quarter
$74.6M
$-9.7M
Free Cash FlowOCF − Capex
$74.6M
$-12.0M
FCF MarginFCF / Revenue
156.3%
-20.2%
Capex IntensityCapex / Revenue
0.0%
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
LPSN
LPSN
Q4 25
$74.6M
$-9.7M
Q3 25
$47.6M
$-6.0M
Q2 25
$-15.1M
$-11.7M
Q1 25
$20.0M
$-3.1M
Q4 24
$15.2M
$-3.1M
Q3 24
$9.9M
$4.8M
Q2 24
$33.5M
$-17.9M
Q1 24
$45.0M
$1.1M
Free Cash Flow
IRWD
IRWD
LPSN
LPSN
Q4 25
$74.6M
$-12.0M
Q3 25
$47.6M
$-8.9M
Q2 25
$-15.1M
$-14.8M
Q1 25
$19.9M
$-6.9M
Q4 24
$-6.8M
Q3 24
$9.9M
$-230.0K
Q2 24
$33.4M
$-22.9M
Q1 24
$44.9M
$-10.4M
FCF Margin
IRWD
IRWD
LPSN
LPSN
Q4 25
156.3%
-20.2%
Q3 25
39.0%
-14.8%
Q2 25
-17.7%
-24.9%
Q1 25
48.4%
-10.6%
Q4 24
-9.2%
Q3 24
10.8%
-0.3%
Q2 24
35.4%
-28.7%
Q1 24
60.0%
-12.2%
Capex Intensity
IRWD
IRWD
LPSN
LPSN
Q4 25
0.0%
3.9%
Q3 25
0.0%
4.8%
Q2 25
0.0%
5.3%
Q1 25
0.1%
5.8%
Q4 24
0.0%
5.0%
Q3 24
0.0%
6.8%
Q2 24
0.1%
6.2%
Q1 24
0.1%
13.5%
Cash Conversion
IRWD
IRWD
LPSN
LPSN
Q4 25
Q3 25
1.19×
-0.69×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
-0.43×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

Related Comparisons